Table 2 Confirmed ATPalpha ^DTS1 interacting deficiencies

DTS1

Control

37.8 +/− 2.6

23

-

-

-

Df(3 L)Exel6092

Sup

76.4 +/− 33.4

11

6.27

spz5, FMRFaR, scramb2, aly

CJ10

Df(2R)ED1725

Sup

209.8 +/− 57.0

6

4.87

Df(2R)BSC361

Sup

87.8 +/− 10.6

16

4.68

Stj

CJ10

Df(3 L)BSC33

Sup

103.9 +/− 34.4

14

4.64

Df(3 L)Exel8104

Enh

27.3 +/− 27.3

11

3.18

Df(3R)BSC486

Enh

17.2 +/− 1.7

19

2.65

CJ10

Df(2 L)BSC180

Sup

85.3 +/− 16.5

25

2.13

Rbp9

CJ10

Df(3R)Exel6210

Sup

151.3 +/− 42.9

11

2.02

Df(2R)BSC383

Sup

129.1 +/− 40.9

11

1.80

Df(2 L)BSC278

Sup

52.3 +/− 14.9

25

1.54

Df(3 L)BSC23

Enh

11.2 +/− 1.1

14

1.53

spz5, scramb2, rasp, aly

CJ5, CJ10

Df(2 L)Exel6005

Sup

73.9 +/− 23.1

19

1.51

Df(3R)BSC650

Enh

22.1 +/− 2.3

13

1.20

Df(2 L)ED1203

Enh

21.2 +/− 2.1

13

0.92

Ham

CJ5

Df(3R)ED2

Enh

20.0 +/− 2.6

25

0.88

Df(2R)ED3728

Sup

46.3 +/− 8.2

15

0.86

Df(1)BSC767

Sup

138.2 +/− 26.7

13

0.82

Df(2R)M60E

Sup

48.1 +/− 5.9

25

0.74

Rpl19, pain

Df(2 L)ED629

Enh

27.1 +/− 2.9

13

0.49

Glutactin, sema-1a

Df(3R)ED7665

Enh/Leth

-

-

CJ10

Df(3R)ED6361

Enh/Leth

-

-

Df(3 L)BSC375

Enh/Leth

-

-

Df(3R)BSC467

Enh/Leth

-

-

CJ10

Df(1)BSC708

Enh/Leth

-

-

Df(3R)BSC819

Enh/Leth

-

-

ATPalpha

All Enh/Leth